S-488210/S-488211 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-488210/S-488211 vaccine, covering 2024-12-04 to 2024-12-04. Get the full timeline:
Most recent: Clinical Trial Update: DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr [Phase 1, Phase 2]